Trial Profile
Use of Patiromer to Transition Chronic Kidney Disease Patients With Hyperkalemia to a Plant-rich Diet.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2021
Price :
$35
*
At a glance
- Drugs Patiromer (Primary)
- Indications Hyperkalaemia
- Focus Proof of concept; Therapeutic Use
- 27 Jul 2020 Planned End Date changed from 1 Apr 2020 to 1 Jun 2021.
- 27 Jul 2020 Planned primary completion date changed from 1 Apr 2020 to 1 Jun 2021.
- 27 Jul 2020 Status changed from recruiting to active, no longer recruiting.